Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ensure Enlive is a specialized oral nutritional supplement (medical food) manufactured by Abbott Nutrition. It is formulated to support muscle health and recovery in patients with malnutrition, muscle wasting, or those recovering from surgery or illness. The key active ingredient is Calcium Beta-Hydroxy-Beta-Methylbutyrate (CaHMB), a metabolite of the amino acid leucine that works to slow muscle breakdown and enhance muscle repair by modulating protein metabolism. Each serving provides 20 grams of high-quality protein, along with vitamin D, calcium, plant-based omega-3 fatty acids (alpha-linolenic acid), and antioxidants. It is used in clinical settings, such as the NutriVasc trial for perioperative optimization in critical limb ischemia (CLI) patients, to improve functional status and clinical outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ensure Enlive.